Back to Search
Start Over
Eli Lilly announces results from two, multi-year mirikizumab studies
- Source :
- The Fly. October 28, 2024
- Publication Year :
- 2024
-
Abstract
- Eli Lilly announced results from two, multi-year, Phase 3 studies that showed patients treated with mirikizumab sustained stable, long-term remission across two types of inflammatory bowel diseases, or IBD, ulcerative [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- The Fly
- Publication Type :
- Periodical
- Accession number :
- edsgcl.813879716